Clinical Trial

Non-invasive Characterisation of Oral Carcinomas in Patients With Fanconi Anaemia

Study acronym: Fanc-Oral
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients with Fanconi anaemia have an increased risk of developing squamous cell carcinoma of the head and neck. In addition, their genetic vulnerability limits the use of genotoxic treatments such as radiotherapy and chemotherapy, due to increased exposure to severe toxicities. Less invasive diagnostic techniques, such as brush biopsies, which rely on cytological and ploidy analysis, offer the possibility of more systematic, comprehensive and less painful oral mapping, thereby facilitating earlier diagnosis.
Trial Details
NCT Number NCT07242261
Lead Sponsor Institut Jean-Godinot
Collaborators: Université de Reims Champagne-Ardenne
Conditions Fanconi Anaemia
Enrollment 115 participants
Start Date 2026-04-01
Primary Completion 2030-04-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-21